Manuel Valladares-Ayerbes

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Ejection Fraction

Cancer Stem Cells

Top Venues

International journal of molecular sciences

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Cancer chemotherapy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Julia Martínez-Pérez, Carlos Torrado, María A Domínguez-Cejudo, Manuel Valladares-Ayerbes
Targeted Treatment against Cancer Stem Cells in Colorectal Cancer. International journal of molecular sciences 25 (11) (2024)
Manuel Valladares-Ayerbes, Maria José Safont, Encarnación González Flores, Pilar García-Alfonso, Enrique Aranda, Ana-Maria López Muñoz, Esther Falcó Ferrer, Luís Cirera Nogueras, Nuria Rodríguez-Salas, Jorge Aparicio, Marta Llanos Muñoz, Paola Patricia Pimentel Cáceres, Oscar Alfredo Castillo Trujillo, Rosario Vidal Tocino, Mercedes Salgado Fernández, Antonieta Salud-Salvia, Bartomeu Massuti Sureda, Rocio Garcia-Carbonero, Maria Ángeles Vicente Conesa, Ariadna Lloansí Vila, null null
Sequential RAS mutations evaluation in cell-free DNA of patients with tissue RAS wild-type metastatic colorectal cancer: the PERSEIDA (Cohort 2) study. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
Julia Martínez-Pérez, Carlos Torrado, María A Domínguez-Cejudo, Manuel Valladares-Ayerbes
Targeted Treatment against Cancer Stem Cells in Colorectal Cancer. International journal of molecular sciences 25 (11) (2024)
Jaime Feliú-Batlle, Mónica Jorge Fernández, Teresa Macarulla, Bartomeu Massuti, Ana Albero, José Federico González González, Guillermo Quintero-Aldana, Juan Ignacio Delgado-Mingorance, Ana Fernández Montes, Carmen García Piernavieja, Manuel Valladares-Ayerbes, Ana María López Muñoz, Rebeca Mondéjar Solís, Pilar Vicente, Esther Casado Gonzalez, Irene González Cebrián, Guillermo López-Vivanco
Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma: the BIBABRAX study. Cancer chemotherapy and pharmacology 87 (4) (2021)